People say these peptides hurt them. Their stories are muffled in MAHA’s push for medical freedom.

“There are millions of success stories with these peptides, but no one wants to believe that this wrecks some of our lives.”

1

BPC-157 and many other experimental peptides lack clinical trial evidence establishing their safety or effectiveness.
2

People who said they took BPC-157 described fatigue, anxiety, twitching, pain, headaches, vision problems, and other adverse effects.
3

A preliminary analysis of millions of deidentified health records found that more than 1,000 people had told doctors they used BPC-157 since 2020.
4

An FDA advisory panel voted to ease restrictions on six experimental peptides, but the FDA has not issued a final decision.
5

FDA scientists cited insufficient evidence of benefit and potential serious harms, while researchers warned that sales without approval could discourage clinical trials.

1